Liver Transplant: Access, Disparities and Allocation

Description

This session examines the structural, geographic, and clinical factors that shape who gains access to liver transplantation and how organs are allocated. Presentations address disparities across the transplant continuum—from waitlist mortality risk and MELD-based allocation to the influence of public perception on donation—highlighting opportunities for more equitable practice. Together, these studies offer evidence to inform allocation reform and reduce inequities in transplant access.

Presentations

5:00 PM - 5:15 PM
Convention Center - Mile High Ballroom 2A-3A
Recorded session

Exploring the Effect of Negative Press on Deceased Donor Liver Donation

Chelsea S Pan, MD | Abstract Presenter
5:15 PM - 5:30 PM
Convention Center - Mile High Ballroom 2A-3A
Recorded session

Sex-Based Disparities in Liver Transplant Allocation Amid MELD 3.0 and the Emergence of Machine Perfusion

Tomohiro Tanaka | Abstract Presenter
5:30 PM - 5:45 PM
Convention Center - Mile High Ballroom 2A-3A
Recorded session

Center-Level Variation in Donation After Circulatory Death Liver Transplantation and Its Association With Access and Outcomes

Katie Ross-Driscoll, PhD, MPH | Abstract Presenter
5:45 PM - 6:00 PM
Convention Center - Mile High Ballroom 2A-3A
Recorded session

Hepatic Encephalopathy Independently Predicts Waitlist Mortality and Reduces Transplant Probability in Cirrhotic Patients: Evidence for MELD-Based Allocation Reform

Neev Mehta | Abstract Presenter
6:00 PM - 6:15 PM
Convention Center - Mile High Ballroom 2A-3A
Recorded session

Increasing Dependence on MELD-Exception Allocation in Contemporary Liver Transplantation: Disease-Specific Differences and Waitlist Outcomes

Shiv Patel, MD | Abstract Presenter
6:15 PM - 6:30 PM
Convention Center - Mile High Ballroom 2A-3A
Recorded session

The PALM (Predicting Access in Low MELD) Score: A new method to identify high mortality risk with low transplant access among low MELD waitlist candidates

Xiaohan Ying, MD | Abstract Presenter

Objectives

  • Identify clinical and structural factors that contribute to disparities in liver transplant access and waitlist mortality among candidates.
  • Evaluate the impact of current MELD-based allocation policies, including MELD 3.0, on equitable organ distribution and outcomes.
  • Describe novel risk-stratification tools (e.g., the PALM score) for identifying high-mortality, low-access candidates who may benefit from allocation adjustments.
  • Discuss how modifiable factorssuch as public perception of donation and emerging technologies like machine perfusionmay expand donor utilization and transplant access.